Jordi Bruix

机构：Hospital Clínic de Barcelona, Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas, Consorci Institut D'Investigacions Biomediques August Pi I Sunyer, Universitat de Barcelona · ORCID：0000-0002-9826-0753

发表论文 703 篇 · 总被引 130157 次 · h-index 130

代表论文

• The Lancet Commission on addressing the global hepatocellular carcinoma burden: comprehensive strategies from prevention to treatment (2025 · The Lancet · 被引 167)
• BCLC strategy for prognosis prediction and treatment recommendations: The 2026 update (2025 · Journal of Hepatology · 被引 144)
• Histological predictors of aggressive recurrence of hepatocellular carcinoma after liver resection (2024 · Journal of Hepatology · 被引 108)
• Liver Transplantation for Hepatocellular Carcinoma: An Expanding Cornerstone of Care in the Era of Immunotherapy (2024 · Journal of Clinical Oncology · 被引 23)
• Recommendations on Perihilar Cholangiocarcinoma. The Milan Jury-Based Consensus (2025 · Annals of Surgery · 被引 19)
• Phase I trial of ADP-A2AFP TCR T-cell therapy in patients with advanced hepatocellular or gastric hepatoid carcinoma (2025 · Journal of Hepatology · 被引 11)